COVID-19 Vaccine Toolkit
The COVID-19 public health emergency (PHE) ended at the end of the day on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.
This toolkit is for health care providers. Review this page for information about the Medicare COVID-19 Vaccines Toolkit during and after the PHE.
This COVID-19 Vaccine Toolkit is for health care providers and includes information to describe:
- The COVID-19 vaccine Medicare coding structure
- Medicare payment rates for administering COVID-19 vaccines, including a timeline of FDA approvals and EUA amendments for COVID-19 vaccines
- How to bill correctly for administering vaccines, including roster and centralized billing
- Monoclonal antibody infusion for treating COVID-19
If you have questions about billing or reimbursement of vaccine administration for patients covered by private insurance or Medicaid, contact the respective health plan or state Medicaid agency.
Patients who are moderately or severely immunocompromised (have a weakened immune system) are at increased risk of severe COVID-19 illness and death. And, the immune response following COVID-19 vaccination may differ for these patients. Learn about COVID-19 vaccine guidance for moderately or severely immunocompromised patients.